BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 6172706)

  • 21. Inosiplex for SSPE.
    Jones C
    Lancet; 1982 Aug; 2(8296):495. PubMed ID: 6180266
    [No Abstract]   [Full Text] [Related]  

  • 22. Inosiplex for SSPE.
    Chalmers TC; Smith H
    Lancet; 1982 Jun; 1(8287):1475. PubMed ID: 6177984
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic experiences with the immunostimulator inosine pranobex].
    Darlath W; Wybran J
    Fortschr Med; 1984 Oct; 102(37):932-4. PubMed ID: 6209193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subacute sclerosing panencephalitis.
    Br Med J; 1979 Nov; 2(6198):1096. PubMed ID: 93011
    [No Abstract]   [Full Text] [Related]  

  • 25. The interferon system in subacute sclerosing panencephalitis and its response to isoprinosine.
    Gadoth N; Kott E; Levin S; Hahn T
    Brain Dev; 1989; 11(5):308-12. PubMed ID: 2479277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trihexyphenidyl and isoprinosine in the treatment of subacute sclerosing panencephalitis.
    Nunes ML; da Costa JC; da Silva LF
    Pediatr Neurol; 1995 Sep; 13(2):153-6. PubMed ID: 8534281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current developments in the management of subacute sclerosing panencephalitis.
    Panagariya A; Sureka RK; Aurora A
    J Assoc Physicians India; 1998 Feb; 46(2):218-20. PubMed ID: 11273118
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of subacute sclerosing panencephalitis: an overview.
    Taylor WJ; DuRant RH; Dyken PR
    Drug Intell Clin Pharm; 1984 May; 18(5):375-81. PubMed ID: 6202474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Subacute sclerosing panencephalitis].
    Aguiar T
    Acta Med Port; 2000; 13(4):193-8. PubMed ID: 11155486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-interferon and isoprinosine in adult-onset subacute sclerosing panencephalitis.
    Gokcil Z; Odabasi Z; Demirkaya S; Eroglu E; Vural O
    J Neurol Sci; 1999 Jan; 162(1):62-4. PubMed ID: 10064170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Report of two children with subacute sclerosing panencephalitis displaying an atypical clinical course.
    Tepebaşili I; Caksen H; Odabaş D; Ataş B; Akbayram S
    J Emerg Med; 2004 Apr; 26(3):356-9. PubMed ID: 15028344
    [No Abstract]   [Full Text] [Related]  

  • 32. Subacute sclerosing panencephalitis: influence of the clinical course and treatment with isoprinosine on non-specific cell-mediated and humoral immunity.
    Vainiene M; Członkowska A; Korlak J
    Acta Neurol Scand; 1983 May; 67(5):275-84. PubMed ID: 6192674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of the results of the treatment of patients with subacute sclerosing panencephalitis with TFX-Polfa].
    Vainiene M; Sobczyk W
    Neurol Neurochir Pol; 1985; 19(4):286-90. PubMed ID: 2419779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of inosiplex treatment on the neurological disability of patients with subacute sclerosing panencephalitis.
    DuRant RH; Dyken PR; Swift AV
    J Pediatr; 1982 Aug; 101(2):288-93. PubMed ID: 6178812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inosiplex therapy in subacute sclerosing panencephalitis. A multicentre, non-randomised study in 98 patients.
    Jones CE; Dyken PR; Huttenlocher PR; Jabbour JT; Maxwell KW
    Lancet; 1982 May; 1(8280):1034-7. PubMed ID: 6176821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subacute sclerosing panencephalitis.
    Gascon GG; Crowell J; Stigsby B; Yamani S
    Neurology; 1993 Feb; 43(2):454-5. PubMed ID: 7679784
    [No Abstract]   [Full Text] [Related]  

  • 37. [Subacute sclerosing panencephalitis - clinical observations].
    Filipowicz A; Motta E; Piekarska-Konstanty A; Kazibutowska Z
    Pediatr Pol; 1983 May; 58(5):471-5. PubMed ID: 6195590
    [No Abstract]   [Full Text] [Related]  

  • 38. Combined oral isoprinosine-intraventricular alpha-interferon therapy for subacute sclerosing panencephalitis.
    Gascon G; Yamani S; Crowell J; Stigsby B; Nester M; Kanaan I; Jallu A
    Brain Dev; 1993; 15(5):346-55. PubMed ID: 7506498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of neurometabolites in subacute sclerosing panencephalitis by 1H-MRS.
    Anlar B
    Neurology; 2007 Apr; 68(17):1438; author reply 1438. PubMed ID: 17452596
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term follow-up of patients with adult-onset subacute sclerosing panencephalitis.
    Eroglu E; Gokcil Z; Bek S; Ulas UH; Ozdag MF; Odabasi Z
    J Neurol Sci; 2008 Dec; 275(1-2):113-6. PubMed ID: 18783800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.